Because energy expenditure is increased within fat cells, the rate of cellular metabolism within these fat cells go up
PROTECT FROM LIGHT Use only if solution is clear and seal intact
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Blood test markers to discuss with a clinician Marker Comprehensive metabolic panel (CMP) Why it matters Reviews liver enzymes, kidney markers, electrolytes, and glucose in one broad safety panel
Treatment upregulated protein translation components and stimulated the transsulfuration pathway for oxidative stress protection, with no reported adverse events (Dimet-Wiley et al., 2024)
